Related Experiment Videos
[Targeting therapy of gastric and colorectal cancer]
T Yamaguchi1, T Takahashi, A Hagiwara
1First Dept. of Surgery, Kyoto Prefectural University of Medicine.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|May 1, 1994
Abstract:
Clinically applied targeting cancer chemotherapy against gastric and colo-rectal cancer were reviewed. The results of such new treatment was not satisfactory. Especially the results of the treatment against colo-rectal cancer was unsatisfactory and new approaches using drug delivery system should be developed. Some of new preclinical experimental approaches were introduced.
Insights
Targeting cancer chemotherapy for gastric and colorectal cancers yielded unsatisfactory results. New drug delivery systems are needed to improve treatment efficacy for these challenging gastrointestinal cancers.
Area of Science:
- Oncology
- Pharmacology
- Gastroenterology
Context:
- Review of current clinical applications of targeted cancer chemotherapy.
- Focus on gastric and colorectal cancer treatments.
Purpose:
- Evaluate the effectiveness of existing chemotherapy regimens.
- Identify limitations and areas for improvement in cancer therapy.
Summary:
- Clinical outcomes for targeted chemotherapy against gastric and colorectal cancers were unsatisfactory.
- Colorectal cancer treatment results were particularly disappointing, highlighting a need for novel strategies.
- Preclinical experimental approaches, including drug delivery systems, were introduced as potential solutions.
Impact:
- Underscores the urgent need for advanced drug delivery systems in oncology.
- Suggests a shift towards innovative therapeutic strategies for gastrointestinal malignancies.
- Provides a basis for future research and development in cancer chemotherapy.